Article

post-gazette.com on 2015-05-01 06:00

Teva still pursuing merger with Mylan

Erez Vigodman

Related news

HTeva Shares Up on Mylan-Pfizer Merger hamodia.com
Wall Street
Teva still targets Mylan despite rejection The Jerusalem Post (JPost.com)
Israel , Jerusalem
Mylan rejects Teva Pharmaceutical's takeover bid post-gazette.com
Wall Street , Ireland
Teva brings in new adviser for proposed Mylan deal bizjournals.com
Chicago , Pittsburgh , New York
Teva CEO: Company’s proposal to Mylan is ‘strong and serious’observer-reporter.com
Netherlands , Southpointe
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Reuters
Netherlands , Tel Aviv , Jerusalem
Teva Pharmaceutical says its offer to buy Mylan is 'strong and serious'post-gazette.com
Pittsburgh , Netherlands , Washington
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bid The Globe and Mail
Netherlands , Tel Aviv
Mylan delays merger with Upjohn due to COVID-19 pandemic bizjournals.com
Mylan completes merger with Upjohn to form Viatris post-gazette.com
Challenges remain for Mylan despite merger with Upjohn bizjournals.com
Bresch to leave CEO job after Mylan merger with Upjohn bizjournals.com
Teva makes $40.1B unsolicited bid for Mylan The Salt Lake Tribune
Netherlands , Poland , Hungary , Brazil , India
Mylan Should Try Teva On for Size wsj.com
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bid business.financialpost.com
New York , Tel Aviv , India , United States , Netherlands
HMylan Overtakes Teva in Market Cap hamodia.com
Wall Street
Teva offers to buy Mylan for $40.1B observer-reporter.com
Southpointe , Ireland , Israel , Netherlands
Teva buying Allergan, drops Mylan bid Philly.com
United States , Montgomery , North Wales , Americas , Pittsburgh
Teva ends hostile bid for Mylan bizjournals.com
Pittsburgh , Netherlands
Teva fires back at Mylan, defending bid, attacking Mylan boss Haaretz